Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Maple Leaf Green World Inc. N.MGW

"Maple Leaf Green World Inc and its subsidiaries focus on the cannabis industry in North America. It operates or funds three cannabis projects, in British Columbia, California, and Nevada. The company applies its eco-agriculture knowledge and cultivation technology to produce contaminant-free organic cannabis products."


NEO:MGW - Post by User

Bullboard Posts
Post by RileyFTWon Apr 09, 2018 9:24am
115 Views
Post# 27851833

News Release: MGW Enters Active Review

News Release: MGW Enters Active Review

ORIGINAL: Maple Leaf Enters “Active Review” with Health Canada on its ACMPR Application

2018-04-09 08:00 ET - News Release

CALGARY, Alberta, April 09, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“Maple Leaf” or the “Company”) (TSX-V:MGW) (OTCQB:MGWFF) is pleased to announce that its application to become a licenced producer under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) has progressed to “active review” status. In the “active review” stage, the Company’s ACMPR application for the Company’s proposed cannabis cultivation facility to be located in Telkwa, British Columbia (the “Telkwa Facility”) will be thoroughly reviewed by Health Canada. The Company anticipates receiving requests for information and will be ready to participate in active communications with the Office of Medical Cannabis of Health Canada for additional information and clarifications to support Maple Leaf’s ACMPR application.

The “active review” stage precedes the issuance of a licence to produce. Upon completion of both the review and the security clearance process, the Company anticipates receiving a confirmation of readiness letter to demonstrate compliance with all the provisions of the ACMPR and the security directive. In order to confirm readiness, the Company will be required to submit information including documentation, photos, and videos of the Telkwa Facility and building plans showing evidence of all physical security measures.

Bullboard Posts